APM logo: click to return home Academy of Psychosomatic Medicine
Psychiatrists Providing Collaborative Care Bridging Physical and Mental Health


Home > Library > Annotated Journal Abstracts > 2017 Q1: Psychonephrology

Annotated Abstracts of Journal Articles
2017, 1st Quarter

Psychonephrology

Annotations by Paula Zimbrean, MD, FAPM, and Marta Novak, MD, PhD
April 2017

  1. Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: A randomized, controlled feasibility trial
PUBLICATION #1 — Psychonephrology
Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: A randomized, controlled feasibility trial
Friedli K, Guirguis A, Almond M, et al
Clin J Am Soc Nephrol 2017; 12(2):280-286
Annotation

The finding: Sertraline showed no benefit over placebo in a randomized controlled trial for treatment of depression in hemodialysis patients.

Strengths and weaknesses: This is a randomized placebo-controlled trial designed to evaluate the efficacy of sertraline for treatment of depression in patients on dialysis. The design was prospective, multicentered; over 700 patients were screened for eligibility. The number of subjects, however, was rather low and the drop-out rate was high. There were significant differences in the drop outs in the sertraline group versus placebo group.

Relevance: Antidepressants are frequently used to treat depression in patients with CKD, including those on hemodialysis; however, there is no systematic data about their efficacy and tolerability. This is the first placebo-controlled trial of an antidepressant in this population. Although the power of the study is not sufficient to draw final conclusions about the efficacy of sertraline in this population, drop outs and side effects were more common in the sertraline group. For the clinician, these results invite caution before starting antidepressants in hemodialysis patients, careful consideration of alternative interventions, and a realistic discussion with patients about risks and benefits of treatment in this situation.

 


Home  •  About  •  Join  •  Members  •  News  •  Annual Meeting  •  Career  •  Education  •  Support


© Academy of Psychosomatic Medicine
JavaScript menu courtesy of Milonic.com